山東赫達(002810.SZ):2021年度擬向相關金融機構申請合計不超10億元融資額度
格隆匯 3 月 16日丨山東赫達(002810.SZ)公佈,公司第八屆董事會第十一次會議決議,審議通過《關於向相關金融機構申請不超過人民幣10億元融資額度的議案》,該議案尚需提交股東大會審議。
同意公司2021年度向相關金融機構申請合計不超過人民幣10億元的融資額度(最終以各家金融機構實際審批為準),授權董事長代表公司簽署上述融資額度項下的有關法律文件,由此產生的法律、經濟責任由公司承擔。上述綜合融資額度授權期限自股東大會通過之日起至2021年度股東大會召開之日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.